ClinConnect ClinConnect Logo
Search / Trial NCT06116084

Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine

Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Oct 30, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring the use of hypnosis to help reduce anxiety in patients undergoing nuclear medicine scans, which can take a long time and require patients to stay still. Anxiety can make it difficult for patients to complete these important tests, so the researchers are comparing two methods of delivering hypnosis: one where a trained professional is physically present with the patient and another delivered remotely. The goal is to see if remote hypnosis can effectively help patients feel more relaxed during their scans, similar to the traditional method.

To participate in this study, patients should be between 18 and 80 years old, understand French, and have a higher than normal anxiety level as determined by a specific questionnaire. They should not have taken anxiety medication before their appointment or have certain health conditions that would prevent them from undergoing the scan. Participants can expect to receive hypnosis to help them manage anxiety before their imaging procedure, which may improve their experience and the quality of the examination. This study is an important step in understanding how hypnosis can enhance patient care in nuclear medicine while also considering safety regulations related to radiation exposure.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient referred for a scan or PET scan
  • Patient with a score \> 11 on the STAI-6 scale.
  • Person, speaking and understanding French
  • Having received complete information on the organization of the research and having signed the informed consent
  • Age ≥ 18 years, and ≤ 80 years.
  • Affiliated with a social security plan.
  • Exclusion Criteria:
  • People who have taken an anxiolytic treatment before going to nuclear medicine.
  • Persons referred for a neurological examination.
  • People with cognitive or auditory problems, or with a major depressive episode.
  • Persons with cardiac rhythm disorders (cardiac arrhythmias)
  • Persons who cannot perform the examination for which they need a hypnosis session
  • Women of childbearing age who do not have an effective means of contraception
  • Person referred to in articles L. 1121-5, L. 1121-7 and L1121-8 of the public health code (pregnant woman, parturient or nursing mother, adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice, adult person unable to express his consent).
  • Person deprived of liberty by a judicial or administrative decision, subject to psychiatric care under articles L. 3212-1 and L. 3213-1

About Central Hospital, Nancy, France

Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.

Locations

Vandoeuvre Les Nancy, , France

Patients applied

0 patients applied

Trial Officials

Martine Louis

Principal Investigator

m.louis2@chru-nancy.fr

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported